Zydus Lifesciences share price today recorded decline of 2.86% on Bombay Stock Exchange (BSE) to Rs 885.30 per share as Sensex declined 643.25 points to 81,416. The company today declared a marginal fall of 1.02% year-on-year (YoY) to Rs 1170.9 crore for Q4FY25 as against Rs 1182.3 crore reported in the corresponding quarter of last year. The company also recommended highest dividend of Rs 11 per equity share of Re 1/- each. It fixed July 25, 2025 as the record date for dividend. Meanwhile, Life Insurance Corporation of India (LIC) increased its stake to 3.85% for March 2025 quarter from 3.53% in December 2024 quarter. FII/FPI reduced holdings from 7.53% to 7.31% for March 2025 quarter. The pharma giant has a market capitalisation of Rs 89,081.90 crore. Check key details below:
Zydus Lifesciences Recommends Final Dividend
The Board also recommended final dividend of Rs. 11/- (@1100%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 12, 2025. This is the highest dividend since 2015 when the company recommended a final dividend of Rs 12 per share.
Zydus Sets Record Date For Final Dividend
The exchange filing added, “The Record Date as Friday, July 25, 2025, in compliance with regulation 42(1) of the Listing Regulations, to determine the list of shareholders entitled to receive the final dividend for the Financial Year ended on March 31, 2025, payment of which shall be subject to the approval by the members at the AGM.” Zydus will hold the thirtieth Annual General Meeting (“AGM”) of the members of the Company on Tuesday, August 12, 2025.
Zydus Lifesciences Q4FY25 Results
The company declared decline in its total revenue from operations to Rs 6527.9 crore for Q4FY25 from Rs 5533.8 crore reported in Q4FY24. Meanwhile, total income of the pharma company zoomed to Rs 6608.5 crore for Q4FY25 from Rs 5690.2 crore. Total expenses declared at Rs 4716.9 crore for the quarter under review as compared to Rs 4143.2 crore declared in Q4FY24. The earning per share of Zydus declined to Rs 11.64 for Q4FY25 from Rs 11.66 in Q4FY24.
“We are happy to conclude FY 2025 on a strong note, with all our businesses surpassing our growth expectations. The commercial success of our extensive product portfolio combined with operating leverage has significantly bolstered profitability and financial health. We made meaningful progress in our differentiated pipeline and added new capabilities to ensure sustainable growth. We look forward to continued execution success and deepening strategic partnerships to drive long term growth. Our commitment to maintaining the highest quality standards across our operations remains unwavering,” said Dr. Sharvil Patel, Managing Director – Zydus Lifesciences Limited.
Zydus Lifesciences Shares Performance
The 52-week high of Zydus Lifesciences share price on BSE stood at Rs 1323.90 per share (as on 09/08/2024) and 52-week low price is Rs 797.05 per share (as on 07/04/2025), respectively. Zydus Life share price slipped 1.84% in last 1-week when Sensex gained 0.36% and BSE Healthcare rose 0.93%. The stock plunged over 19% in last 1-year, gained 79.06% in last 2-years, and offered returns of 147.82% in last 3-years.
Zydus Lifesciences Dividend History
The company announced a total of 22 dividends since 2003. In last 1-year, it recommended an equity dividend of Rs 3.00 per share. Its dividend yield is 0.34%.
Disclaimer: The story highlights results, dividend, and should not be considered as investment advice by the Moneydaily.in or the Author. Moneydaily.in and the author will not be held responsible for any losses caused as a result of decisions based on the above information. Moneydaily.in advises readers to do their own research or consult a SEBI registered investment advisor before making any investment decisions.
Recommended: BEL Q4 Results 2025: PSU Declares 18.36% Jump In Net Profit, 90% Dividend
Leave a Reply